Fatty Liver Disease (NASH) Clinical Research Study Enrolling Now in West Palm Beach FL
The SYNCHRONY Histology study is a clinical study to see what effect an investigational drug, EFX, has on scarring of the liver in NASH. AII participants will need to have NASH shown in a liver biopsy (sample of liver tissue). The biopsy may be obtained previously (within 180 days of screening visit), or during the screening process.
We are looking for adults 18 – 80 years of age who have been diagnosed with fatty liver (NASH) and fibrosis. The clinical research study will evaluate the safety and effectiveness of an investigational drug on scarring of the liver in NASH.
For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: www.metabolic-institute.com/nash-clinical-trial/
